Co-Authors
This is a "connection" page, showing publications co-authored by GARY E GALLICK and EDMUND SCOTT KOPETZ.
Connection Strength
1.491
-
Src activity is modulated by oxaliplatin and correlates with outcomes after hepatectomy for metastatic colorectal cancer. BMC Cancer. 2014 Sep 10; 14:660.
Score: 0.514
-
Synergistic activity of the SRC family kinase inhibitor dasatinib and oxaliplatin in colon carcinoma cells is mediated by oxidative stress. Cancer Res. 2009 May 01; 69(9):3842-9.
Score: 0.354
-
Src continues aging: current and future clinical directions. Clin Cancer Res. 2007 Dec 15; 13(24):7232-6.
Score: 0.322
-
Resistance to BRAF inhibition in BRAF-mutant colon cancer can be overcome with PI3K inhibition or demethylating agents. Clin Cancer Res. 2013 Feb 01; 19(3):657-67.
Score: 0.114
-
ALDH activity selectively defines an enhanced tumor-initiating cell population relative to CD133 expression in human pancreatic adenocarcinoma. PLoS One. 2011; 6(6):e20636.
Score: 0.103
-
Src family kinases as mediators of endothelial permeability: effects on inflammation and metastasis. Cell Tissue Res. 2009 Jan; 335(1):249-59.
Score: 0.085